MedKoo Cat#: 532651 | Name: SB-219994

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SB-219994 is a bioactive chemical.

Chemical Structure

SB-219994
SB-219994
CAS#177785-17-0

Theoretical Analysis

MedKoo Cat#: 532651

Name: SB-219994

CAS#: 177785-17-0

Chemical Formula: C21H21F3N2O5

Exact Mass: 438.1403

Molecular Weight: 438.40

Elemental Analysis: C, 57.53; H, 4.83; F, 13.00; N, 6.39; O, 18.25

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
SB-219994; SB219994; SB 219994.
IUPAC/Chemical Name
(2S)-3-[4-[2-(1,3-benzoxazol-2-yl-methylamino)ethoxy]phenyl]-2-(2,2,2-trifluoroethoxy)propanoic acid
InChi Key
QKRDCLQWEHDDOR-SFHVURJKSA-N
InChi Code
InChI=1S/C21H21F3N2O5/c22-21(23,24)13-30-18(20(27)28)11-14-5-7-15(8-6-14)29-10-9-25-12-19-26-16-3-1-2-4-17(16)31-19/h1-8,18,25H,9-13H2,(H,27,28)/t18-/m0/s1
SMILES Code
O=C(O)[C@@H](OCC(F)(F)F)CC1=CC=C(OCCNCC2=NC3=CC=CC=C3O2)C=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 438.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Birrell MA, Patel HJ, McCluskie K, Wong S, Leonard T, Yacoub MH, Belvisi MG. PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. Eur Respir J. 2004 Jul;24(1):18-23. PubMed PMID: 15293600. 2: White IR, Man WJ, Bryant D, Bugelski P, Camilleri P, Cutler P, Hayes W, Holbrook JD, Kramer K, Lord PG, Wood J. Protein expression changes in the Sprague Dawley rat liver proteome following administration of peroxisome proliferator activated receptor alpha and gamma ligands. Proteomics. 2003 Apr;3(4):505-12. PubMed PMID: 12687617. 3: Bryant DK, Monté S, Man WJ, Kramer K, Bugelski P, Neville W, White IR, Camilleri P. Principal component analysis of mass spectra of peptides generated from the tryptic digestion of protein mixtures. Rapid Commun Mass Spectrom. 2001;15(6):418-27. PubMed PMID: 11291120. 4: Young PW, Buckle DR, Cantello BC, Chapman H, Clapham JC, Coyle PJ, Haigh D, Hindley RM, Holder JC, Kallender H, Latter AJ, Lawrie KW, Mossakowska D, Murphy GJ, Roxbee Cox L, Smith SA. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma. J Pharmacol Exp Ther. 1998 Feb;284(2):751-9. PubMed PMID: 9454824.